Filana Therapeutics
FLNA
180 hedge funds and large institutions have $757M invested in Filana Therapeutics in 2021 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 70 increasing their positions, 42 reducing their positions, and 38 closing their positions.
67% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 42
37% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 38
7% more funds holding
Funds holding: 169 → 180 (+11)
3.32% more ownership
Funds ownership: 27.1% → 30.42% (+3.3%)
10% less call options, than puts
Call options by funds: $304M | Put options by funds: $338M
15% less capital invested
Capital invested by funds: $891M → $757M (-$134M)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Norges Bank
Oslo,
Norway
|
+$24.2M |
| 2 |
SC
Sculptor Capital
New York
|
+$19.7M |
| 3 |
Voloridge Investment Management
Jupiter,
Florida
|
+$18.6M |
| 4 |
Morgan Stanley
New York
|
+$16M |
| 5 |
CAC
Cowen and Company
New York
|
+$14.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BL
Bleichroeder LP
New York
|
-$32M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$24.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$12.9M |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$11.4M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$6.38M |
FLNA Hedge Fund Activity: Q3 2021 in Review
180 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2021, worth a combined $757M — down 15% from $891M a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new FLNA positions and 38 closed out — a net gain of 14 holders — while 70 added to existing stakes and 42 trimmed.
The largest buyer was Norges Bank, opening a new position worth an estimated $24.2M. The largest seller was Bleichroeder LP, exiting entirely with an estimated $32M sold.
- 180 institutional investors held Filana Therapeutics (FLNA) as of Q3 2021, up from 169 in Q2 2021.
- Funds reported $757M of Filana Therapeutics stock for Q3 2021, down 15% quarter-over-quarter.
- 52 funds opened new Filana Therapeutics positions in Q3 2021 and 38 closed out, a net change of +14 holders.
- The largest Filana Therapeutics buyer in Q3 2021 was Norges Bank, an estimated $24.2M added.
- The largest Filana Therapeutics seller in Q3 2021 was Bleichroeder LP, an estimated $32M sold.
Based on aggregated 13F filings for Q3 2021.